Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 49.12 million as of June 25, 2025. Its market cap has increased by 40.46% in one year.

Market Cap

49.12M

Enterprise Value

40.44M

Revenue

29.69M

Ranking

n/a

PE Ratio

10.09

Stock Price

3.85

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 49.12M, an increase of 229.88%. That is a compound annual growth rate of 7.49%.

Market Cap History

Date	Market Cap	% Change
Jun 17, 2025	49.12M	0.35%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	35.35M	-1.04%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Palestine Telecommunications Company P.L.C	572.57M
Bank of Palestine	297.78M
Palestine Development & Investment Co.	230.46M
Arab Palestinian Investment Company	213.21M
Wataniya Palestine Mobile Telecommunication - Public Shareholding Company	182.76M
Arkaan Real Estate P.L.C	157.69M
The National Bank	112.23M
Birzeit Pharmaceuticals Company	103.07M

Market Cap Rankings